Company Filing History:
Years Active: 2024
Title: Innovations in Cancer Treatment by Iris Scherwitzl
Introduction
Iris Scherwitzl is a notable inventor based in Hoboken, NJ, who has made significant contributions to the field of cancer treatment. With a focus on enhancing antitumor immunity, her work involves the use of viral vectors and polynucleotides to develop innovative therapeutic methods.
Latest Patents
Iris Scherwitzl holds a patent titled "Induction and enhancement of antitumor immunity involving virus vectors expressing multiple epitopes of tumor associated antigens and immune checkpoint inhibitors or proteins." This patent provides a detailed description of polynucleotides and viral vectors, such as alphavirus or Sindbis viral vectors, that encode multiple epitopes of tumor-associated antigens. Each epitope is strategically separated by processing or enzyme cleavage sites, allowing for effective immune response generation. The patent also discusses the encoding of immune checkpoint proteins, which can be fused to immunoglobulin domains, enhancing the therapeutic potential of the treatment. The methods outlined in her patent aim to treat subjects with cancer or tumors, leading to increased survivability and immune response.
Career Highlights
Iris Scherwitzl is affiliated with New York University, where she continues her research and development in the field of immunotherapy. Her innovative approach to cancer treatment has positioned her as a key figure in the ongoing battle against cancer.
Collaborations
Iris has collaborated with notable colleagues, including Daniel Meruelo and Alicia Hurtado Martinez, who contribute to her research efforts and the advancement of cancer therapies.
Conclusion
Iris Scherwitzl's work exemplifies the intersection of innovation and healthcare, particularly in the realm of cancer treatment. Her patent and ongoing research efforts highlight the potential for viral vectors to enhance antitumor immunity, paving the way for future advancements in cancer therapies.